Literature DB >> 19374978

Chapter 2. From microbial products to novel drugs that target a multitude of disease indications.

Flavia Marinelli1.   

Abstract

More than 20,000 bioactive, so-called microbial secondary metabolites are known. In nature, they can play many different roles as antibiotics, toxins, ionophores, bioregulators, and in intra- and interspecific signaling. Their most versatile producers are differentiating filamentous fungi and actinomycetes, followed by other bacteria such as Bacillus, Pseudomonas, Myxobacteria, and Cyanobacteria. From a biotechnological point of view, bioactive metabolites have been mainly studied as potential anti-infectives (antibacterials, antifungals, antivirals, and antiparasitics). Many of them, originally discovered for their antibiotic activity, were developed further to become leading anticancer drugs, immunosuppressive agents for organ transplantation, and successful pharmaceuticals targeting metabolic and cardiovascular diseases. Old and novel antitumor antibiotics can be divided into two groups spanning diverse chemical classes: those causing some damage to the DNA such as Mitomycins (quinones), Bleomycins (glycopeptides), Actinomycins (peptides), Anthracyclines (aromatic polyketides), Pentostatin (nucleoside), Enediynes (polyketides), and Rebeccamycin derivatives (indolocarbazole glycosides)-all produced by Streptomyces strains or related genera; and the group of tubulin-targeting molecules such as plant/fungal Taxanes (terpenes), myxobacterial Epothilones (macrocyclic polyketides), and the revisited Cryptophycins (peptolides) produced by cyanobacteria. Immunosuppressive agents used in clinical practice include Cyclosporin A (cyclopeptide) and an ester of Mycophenolic acid (small aromatic polyketide), both produced by fungi, and two streptomycete macrocyclic polyketides, Sirolimus (rapamycin) and Tacrolimus (FK506). Statins include a group of fungal polyketides (Compactin or Mevastatin, Lovastatin) and their derivatives, which specifically inhibit cholesterologenesis in liver, and represent the best-selling drugs. They have been used to prevent cardiovascular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19374978     DOI: 10.1016/S0076-6879(09)04802-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  10 in total

Review 1.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

2.  Fungal polyketide synthase product chain-length control by partnering thiohydrolase.

Authors:  Angelica O Zabala; Yit-Heng Chooi; Moon Seok Choi; Hsiao-Ching Lin; Yi Tang
Journal:  ACS Chem Biol       Date:  2014-05-29       Impact factor: 5.100

3.  Pep2Path: automated mass spectrometry-guided genome mining of peptidic natural products.

Authors:  Marnix H Medema; Yared Paalvast; Don D Nguyen; Alexey Melnik; Pieter C Dorrestein; Eriko Takano; Rainer Breitling
Journal:  PLoS Comput Biol       Date:  2014-09-04       Impact factor: 4.475

4.  Structure and mechanism of a dehydratase/decarboxylase enzyme couple involved in polyketide β-methyl branch incorporation.

Authors:  Asha V Nair; Alice Robson; Thomas D Ackrill; Marisa Till; Matthew J Byrne; Catherine R Back; Kavita Tiwari; Jonathan A Davies; Christine L Willis; Paul R Race
Journal:  Sci Rep       Date:  2020-09-18       Impact factor: 4.379

5.  Streptomyces spp. as efficient expression system for a D,D-peptidase/D,D-carboxypeptidase involved in glycopeptide antibiotic resistance.

Authors:  Elisa Binda; Giorgia Letizia Marcone; Francesca Berini; Loredano Pollegioni; Flavia Marinelli
Journal:  BMC Biotechnol       Date:  2013-03-16       Impact factor: 2.563

6.  A Novel Microbisporicin Producer Identified by Early Dereplication during Lantibiotic Screening.

Authors:  Lucia Carrano; Monica Abbondi; Paola Turconi; Gianpaolo Candiani; Flavia Marinelli
Journal:  Biomed Res Int       Date:  2015-08-04       Impact factor: 3.411

Review 7.  Antibacterial Discovery and Development: From Gene to Product and Back.

Authors:  Victor Fedorenko; Olga Genilloud; Liliya Horbal; Giorgia Letizia Marcone; Flavia Marinelli; Yossi Paitan; Eliora Z Ron
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

Review 8.  Bacterial Responses and Genome Instability Induced by Subinhibitory Concentrations of Antibiotics.

Authors:  Luisa Laureti; Ivan Matic; Arnaud Gutierrez
Journal:  Antibiotics (Basel)       Date:  2013-03-14

Review 9.  Old and New Glycopeptide Antibiotics: Action and Resistance.

Authors:  Elisa Binda; Flavia Marinelli; Giorgia Letizia Marcone
Journal:  Antibiotics (Basel)       Date:  2014-11-04

10.  Repurposing Screen Identifies Unconventional Drugs With Activity Against Multidrug Resistant Acinetobacter baumannii.

Authors:  Yu-Shan Cheng; Wei Sun; Miao Xu; Min Shen; Mozna Khraiwesh; Richard J Sciotti; Wei Zheng
Journal:  Front Cell Infect Microbiol       Date:  2019-01-04       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.